134 related articles for article (PubMed ID: 37461125)
1. Impairment of health-related quality of life for children with acute lymphoblastic leukemia over the first year of therapy: A report from the DFCI ALL Consortium.
Welch JJG; Flamand Y; Stevenson KE; Neuberg DS; Athale UH; Kelly KM; Laverdiere C; Michon B; Place AE; Sallan SE; Silverman LB; Vrooman LM
Pediatr Blood Cancer; 2023 Nov; 70(11):e30560. PubMed ID: 37461125
[TBL] [Abstract][Full Text] [Related]
2. Intravenous pegylated asparaginase versus intramuscular native Escherichia coli L-asparaginase in newly diagnosed childhood acute lymphoblastic leukaemia (DFCI 05-001): a randomised, open-label phase 3 trial.
Place AE; Stevenson KE; Vrooman LM; Harris MH; Hunt SK; O'Brien JE; Supko JG; Asselin BL; Athale UH; Clavell LA; Cole PD; Kelly KM; Laverdiere C; Leclerc JM; Michon B; Schorin MA; Welch JJ; Lipshultz SE; Kutok JL; Blonquist TM; Neuberg DS; Sallan SE; Silverman LB
Lancet Oncol; 2015 Dec; 16(16):1677-90. PubMed ID: 26549586
[TBL] [Abstract][Full Text] [Related]
3. Anxiety, pain, and nausea during the treatment of standard-risk childhood acute lymphoblastic leukemia: A prospective, longitudinal study from the Children's Oncology Group.
Dupuis LL; Lu X; Mitchell HR; Sung L; Devidas M; Mattano LA; Carroll WL; Winick N; Hunger SP; Maloney KW; Kadan-Lottick NS
Cancer; 2016 Apr; 122(7):1116-25. PubMed ID: 26773735
[TBL] [Abstract][Full Text] [Related]
4. Fatigue in children who have recently completed treatment for acute lymphoblastic leukemia: a longitudinal study.
Walsh S; Mulraney M; McCarthy MC; De Luca CR
Health Qual Life Outcomes; 2024 Mar; 22(1):27. PubMed ID: 38519964
[TBL] [Abstract][Full Text] [Related]
5. Sleep, fatigue, depression, and quality of life in survivors of childhood acute lymphoblastic leukemia.
Gordijn MS; van Litsenburg RR; Gemke RJ; Huisman J; Bierings MB; Hoogerbrugge PM; Kaspers GJ
Pediatr Blood Cancer; 2013 Mar; 60(3):479-85. PubMed ID: 22887764
[TBL] [Abstract][Full Text] [Related]
6. Impaired sleep affects quality of life in children during maintenance treatment for acute lymphoblastic leukemia: an exploratory study.
van Litsenburg RR; Huisman J; Hoogerbrugge PM; Egeler RM; Kaspers GJ; Gemke RJ
Health Qual Life Outcomes; 2011 Apr; 9():25. PubMed ID: 21496357
[TBL] [Abstract][Full Text] [Related]
7. Longitudinal analysis of quality-of-life outcomes in children during treatment for acute lymphoblastic leukemia: A report from the Children's Oncology Group AALL0932 trial.
Zheng DJ; Lu X; Schore RJ; Balsamo L; Devidas M; Winick NJ; Raetz EA; Loh ML; Carroll WL; Sung L; Hunger SP; Angiolillo AL; Kadan-Lottick NS
Cancer; 2018 Feb; 124(3):571-579. PubMed ID: 29112230
[TBL] [Abstract][Full Text] [Related]
8. Parent proxy-reported health-related quality of life and fatigue in pediatric patients diagnosed with brain tumors and acute lymphoblastic leukemia.
Meeske K; Katz ER; Palmer SN; Burwinkle T; Varni JW
Cancer; 2004 Nov; 101(9):2116-25. PubMed ID: 15389475
[TBL] [Abstract][Full Text] [Related]
9. Asparaginase-associated myelosuppression and effects on dosing of other chemotherapeutic agents in childhood acute lymphoblastic leukemia.
Merryman R; Stevenson KE; Gostic WJ; Neuberg D; O'Brien J; Sallan SE; Silverman LB
Pediatr Blood Cancer; 2012 Nov; 59(5):925-7. PubMed ID: 22532399
[TBL] [Abstract][Full Text] [Related]
10. Health-related quality of life in Japanese children with acute lymphoblastic leukemia during and after chemotherapy.
Kobayashi K; Nakagami-Yamaguchi E; Hayakawa A; Adachi S; Hara J; Tokimasa S; Ohta H; Hashii Y; Rikiishi T; Sawada M; Kuriyama K; Kohdera U; Kamibeppu K; Kawasaki H; Oda M; Hori H
Pediatr Int; 2017 Feb; 59(2):145-153. PubMed ID: 27422759
[TBL] [Abstract][Full Text] [Related]
11. Improved outcome for children with acute lymphoblastic leukemia: results of Dana-Farber Consortium Protocol 91-01.
Silverman LB; Gelber RD; Dalton VK; Asselin BL; Barr RD; Clavell LA; Hurwitz CA; Moghrabi A; Samson Y; Schorin MA; Arkin S; Declerck L; Cohen HJ; Sallan SE
Blood; 2001 Mar; 97(5):1211-8. PubMed ID: 11222362
[TBL] [Abstract][Full Text] [Related]
12. Evaluation for inherited and acquired prothrombotic defects predisposing to symptomatic thromboembolism in children with acute lymphoblastic leukemia: a protocol for a prospective, observational, cohort study.
Athale UH; Laverdiere C; Nayiager T; Delva YL; Foster G; Thabane L; Chan AK
BMC Cancer; 2017 May; 17(1):313. PubMed ID: 28472942
[TBL] [Abstract][Full Text] [Related]
13. Quality of life in children with acute lymphoblastic leukaemia.
Jankowska-Polańska B; Sliwiński M; Świątoniowska N; Butrym A; Mazur G
Scand J Caring Sci; 2020 Jun; 34(2):380-389. PubMed ID: 31334869
[TBL] [Abstract][Full Text] [Related]
14. Quality of life in children and adolescents after treatment for acute lymphoblastic leukemia according to the NOPHO ALL2008 protocol.
Mogensen N; Kreicbergs U; Albertsen BK; Lähteenmäki PM; Heyman M; Harila A
Pediatr Blood Cancer; 2024 Jul; 71(7):e31018. PubMed ID: 38644601
[TBL] [Abstract][Full Text] [Related]
15. A prospective study of anxiety, depression, and behavioral changes in the first year after a diagnosis of childhood acute lymphoblastic leukemia: a report from the Children's Oncology Group.
Myers RM; Balsamo L; Lu X; Devidas M; Hunger SP; Carroll WL; Winick NJ; Maloney KW; Kadan-Lottick NS
Cancer; 2014 May; 120(9):1417-25. PubMed ID: 24473774
[TBL] [Abstract][Full Text] [Related]
16. Antimetabolite-based therapy in childhood T-cell acute lymphoblastic leukemia: a report of POG study 9296.
Winter SS; Holdsworth MT; Devidas M; Raisch DW; Chauvenet A; Ravindranath Y; Ducore JM; Amylon MD
Pediatr Blood Cancer; 2006 Feb; 46(2):179-86. PubMed ID: 16007607
[TBL] [Abstract][Full Text] [Related]
17. Prospective, longitudinal assessment of quality of life in children from diagnosis to 3 months off treatment for standard risk acute lymphoblastic leukemia: Results of Children's Oncology Group study AALL0331.
Mitchell HR; Lu X; Myers RM; Sung L; Balsamo LM; Carroll WL; Raetz E; Loh ML; Mattano LA; Winick NJ; Devidas M; Hunger SP; Maloney K; Kadan-Lottick NS
Int J Cancer; 2016 Jan; 138(2):332-9. PubMed ID: 26235006
[TBL] [Abstract][Full Text] [Related]
18. Health-related quality of life and its determinants during and after treatment for paediatric acute lymphoblastic leukaemia: a national, prospective, longitudinal study in the Netherlands.
Schwartz ER; Rensen N; Steur LMH; Gemke R; van Eijkelenburg NKA; van der Sluis IM; Dors N; van den Bos C; Tissing WJE; Grootenhuis MA; Kaspers GJL; Van Litsenburg RRL
BMJ Open; 2023 Oct; 13(10):e070804. PubMed ID: 37899146
[TBL] [Abstract][Full Text] [Related]
19. PEG-asparaginase allergy in children with acute lymphoblastic leukemia in the NOPHO ALL2008 protocol.
Henriksen LT; Harila-Saari A; Ruud E; Abrahamsson J; Pruunsild K; Vaitkeviciene G; Jónsson ÓG; Schmiegelow K; Heyman M; Schrøder H; Albertsen BK;
Pediatr Blood Cancer; 2015 Mar; 62(3):427-33. PubMed ID: 25418987
[TBL] [Abstract][Full Text] [Related]
20. Comparison of hypersensitivity rates to intravenous and intramuscular PEG-asparaginase in children with acute lymphoblastic leukemia: A meta-analysis and systematic review.
Hasan H; Shaikh OM; Rassekh SR; Howard AF; Goddard K
Pediatr Blood Cancer; 2017 Jan; 64(1):81-88. PubMed ID: 27578304
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]